Safety and Efficacy of a Single Dose of Anti-D (WinRho(®)) in Severe Thrombocytopenia Secondary to Dengue Virus Infection

OBJECTIVE: To evaluate the efficacy of a single intravenous (IV) dose of anti-D in severe thrombocytopenia (<20,000) due to dengue virus (DEV) infection. MATERIALS AND METHODS: An open label, investigator-initiated, randomized interventional study was conducted that included thirty dengue patient...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Indian J Crit Care Med
Главные авторы: Pannu, Ashok Kumar, Bhalla, Ashish, Singhal, Mayank, Suri, Vikas, Shafiq, Nusrat, Varma, Subhash
Формат: Artigo
Язык:Inglês
Опубликовано: Medknow Publications & Media Pvt Ltd 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330058/
https://ncbi.nlm.nih.gov/pubmed/28250602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijccm.IJCCM_386_16
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы